Cargando…
Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
Significant advancements have been made in the treatment of locally advanced head and neck cancer, predominantly driven by the integration of concurrent chemotherapy with radiation therapy as a standard of care for many patients. The most heavily investigated chemotherapeutic is cisplatin, yet many...
Autores principales: | Kim, Sangwoo S., Liu, Hannah C., Mell, Loren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992074/ https://www.ncbi.nlm.nih.gov/pubmed/36696081 http://dx.doi.org/10.1007/s11864-023-01051-w |
Ejemplares similares
-
Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023) -
Exercise program design considerations for head and neck cancer survivors
por: Midgley, Adrian W., et al.
Publicado: (2017) -
Supratracheal laryngectomy:
current indications and contraindications
por: SUCCO, G., et al.
Publicado: (2015) -
Quantitative clinical outcomes of therapy for head and neck lymphedema
por: Doke, Kaleigh N., et al.
Publicado: (2018) -
Salvage surgery for locoregional recurrences
of advanced pharyngolaryngeal squamous cell
carcinoma after organ preservation failure
por: LÓPEZ DELGADO, I., et al.
Publicado: (2014)